Tony Malmqvist

Tony Malmqvist

Auto-generated profile, based on publicly available information

Tony Malmqvist

Atlas Antibodies AB, Bromma, Sweden

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2015 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MGMaria B. Goncalves
Maria B. Goncalves
TMTony Malmqvist
Tony Malmqvist
ECEarl Clarke
Earl Clarke
CHChantal J. Hubens
Chantal J. Hubens
JGJohn Grist
John Grist
JCJonathan P.T Corcoran
Jonathan P.T Corcoran
Failure of axonal regeneration in the central nervous system (CNS) is mainly attributed to a lack of intrinsic neuronal growth programs and an inhibitory environment from a glial scar. Phosphatase and tensin homolog (PTEN) is a major negative regulator of neuronal regeneration and, as such, inhibiting its activity has been considered a therapeutic target for spinal cord (SC) injuries (SCIs). Using a novel model of rat cervical avulsion, we show that treatment with a retinoic acid receptor β (RARβ) agonist results in locomotor and sensory recovery. Axonal regeneration from the severed roots into the SC could be seen by biotinylated dextran amine labeling. Light micrographs of the dorsal root entry zone show the peripheral nervous system (PNS)–CNS transition of regrown axons. RARβ agonist treatment also resulted in the absence of scar formation. Mechanism studies revealed that, in RARβ-agonist-treated neurons, PTEN activity is decreased by cytoplasmic phosphorylation and increased secretion in exosomes. These are taken up by astrocytes, resulting in hampered proliferation and causing them to arrange in a normal-appearing scaffold around the regenerating axons. Attribution of the glial modulation to neuronal PTEN in exosomes was demonstrated by the use of an exosome inhibitorin vivoand PTEN siRNAin vitroassays. The dual effect of RARβ signaling, both neuronal and neuronal–glial, results in axonal regeneration into the SC after dorsal root neurotmesis. Targeting this pathway may open new avenues for the treatment of SCIs.SIGNIFICANCE STATEMENTSpinal cord injuries (SCIs) often result in permanent damage in the adult due to the very limited capacity of axonal regeneration. Intrinsic neuronal programs and the formation of a glial scar are the main obstacles. Here, we identify a single target, neuronal retinoic acid receptor β (RARβ), which modulates these two aspects of the postinjury physiological response. Activation of RARβ in the neuron inactivates phosphatase and tensin homolog and induces its transfer into the astrocytes in small vesicles, where it prevents scar formation. This may open new therapeutic avenues for SCIs.

4 February 2013 in European Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MGMaria B. Goncalves
Maria B. Goncalves
ECEarl Clarke
Earl Clarke
CHCarl Hobbs
Carl Hobbs
TMTony Malmqvist
Tony Malmqvist
RDRobert Deacon
Robert Deacon
JCJonathan P. T. Corcoran
Jonathan P. T. Corcoran
The retinoic acid receptor (RAR) α system plays a key role in the adult brain, participating in the homeostatic control of synaptic plasticity, essential for memory function. Here we show that RARα signalling is down‐regulated by amyloid beta (Aβ), which inhibits the synthesis of the endogenous ligand, retinoic acid (RA). This results in the counteraction of a variety of RARα‐activated pathways that are key in the aetiopathology of Alzheimer's disease (AD) but which can be reversed by an RARα agonist. RARα signalling improves cognition in the Tg2576 mice, it has an anti‐inflammatory effect and promotes Aβ clearance by increasing insulin degrading enzyme and neprilysin activity in both microglia and neurons. In addition, RARα signalling prevents tau phosphorylation. Therefore, stimulation of the RARα signalling pathway using a synthetic agonist, by both clearing Aβ and counteracting some of its toxic effects, offers therapeutic potential for the treatment of AD.

23 March 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OKO. Andreas Karlsson
O. Andreas Karlsson
JRJuan Ramirez
Juan Ramirez
DÖDaniel Öberg
Daniel Öberg
TMTony Malmqvist
Tony Malmqvist
ÅEÅke Engström
Åke Engström
PJPer Jemth
Per Jemth
Chronic infection by high risk human papillomavirus (HPV) strains may lead to cancer. Expression of the two viral oncoproteins E6 and E7 is largely responsible for immortalization of infected cells. The HPV E6 is a small (approximately 150 residues) two domain protein that interacts with a number of cellular proteins including the ubiquitin ligase E6-associated protein (E6AP) and several PDZ-domain containing proteins. Our aim was to design a high-affinity binder for HPV E6 by linking two of its cellular targets. First, we improved the affinity of the second PDZ domain from SAP97 for the C-terminus of HPV E6 from the high-risk strain HPV18 using phage display. Second, we added a helix from E6AP to the N-terminus of the optimized PDZ variant, creating a chimeric bivalent binder, denoted PDZbody. Full-length HPV E6 proteins are difficult to express and purify. Nevertheless, we could measure the affinity of the PDZbody for E6 from another high-risk strain, HPV16 (Kd = 65 nM). Finally, the PDZbody was used to co-immunoprecipitate E6 protein from HPV18-immortalized HeLa cells, confirming the interaction between PDZbody and HPV18 E6 in a cellular context.

13 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
DRDoroteya Raykova
Doroteya Raykova
DKDespoina Kermpatsou
Despoina Kermpatsou
TMTony Malmqvist
Tony Malmqvist
PHPhilip J. Harrison
Philip J. Harrison
MSMarie Rubin Sander
Marie Rubin Sander
OSOla Söderberg
Ola Söderberg
Determining the levels of protein–protein interactions is essential for the analysis of signaling within the cell, characterization of mutation effects, protein function and activation in health and disease, among others. Herein, we describe MolBoolean – a method to detect interactions between endogenous proteins in various subcellular compartments, utilizing antibody-DNA conjugates for identification and signal amplification. In contrast to proximity ligation assays, MolBoolean simultaneously indicates the relative abundances of protein A and B not interacting with each other, as well as the pool of A and B proteins that are proximal enough to be considered an AB complex. MolBoolean is applicable both in fixed cells and tissue sections. The specific and quantifiable data that the method generates provide opportunities for both diagnostic use and medical research.

1 October 2014 in Brain Research
Verified
Journal Article
Closed access
TMTony Malmqvist
Tony Malmqvist
KAKaren Anthony
Karen Anthony
JGJean-Marc Gallo
Jean-Marc Gallo

6 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
DRDoroteya Raykova
Doroteya Raykova
DKDespoina Kermpatsou
Despoina Kermpatsou
TMTony Malmqvist
Tony Malmqvist
PHPhilip J. Harrison
Philip J. Harrison
MSMarie Rubin Sander
Marie Rubin Sander
OSOla Söderberg
Ola Söderberg